Seed Round

A new, self-administered RNA therapy for hereditary angioedema gains EU approval, promising fewer attacks and greater freedom for thousands of patients.

Wendel Investment Managers' affiliates raise over €11 billion, validating the firm's strategic pivot and defying a tough private capital market.

Crosswalk Therapeutics secures a key grant to develop a therapy targeting the debilitating skeletal disease in Morquio A, a challenge current treatments can't solve.

American Lithium Minerals acquires a high-grade gold claim in BC's Golden Triangle while pivoting to a revolutionary but risky blockchain financing model.

Amid a rebounding SPAC market, FG Imperii Acquisition Corp. launches a $200M IPO, targeting North America's financial services sector with a veteran team.

A new bio-based adhesive from BioBond aims to replace screws and welding in defense and mobility, promising high performance and rural job growth.

Flywl's platform now spans AWS, Azure, and Google Cloud, offering a single command center to tame complex multi-cloud software spending and procurement.

The investment firm celebrated a strong 2025 with shareholder payouts, fueled by profitable exits and a new major investment in AI infrastructure firm TensorWave.

Biotech veteran Kamran Tavangar, who built a multi-billion dollar company at LabCentral, returns to lead its science strategy and shape the future of innovation.

A new campaign says indecision is the biggest business risk. Aily Labs' AI platform promises to end analysis paralysis and force confident, fast action.

Record AI mega-deals redefine healthcare innovation, yet a broader market contraction creates a new divide for startups and traditional medical sectors.

Kelonia Therapeutics gets the FDA green light to expand trials for its in vivo CAR-T therapy, a single-infusion treatment that could redefine cancer care.

A new universal operating system and app store, QwikOS, launches to standardize humanoid robots, making them more accessible to developers and users.

Prenetics slashed future dilution risk by exchanging 4.7M warrants, a move analysts see as crucial for fueling the rapid growth of its IM8 wellness brand.

Abingworth elevates Bali Muralidhar and hires Travis Wilson, signaling a major push into clinical co-development and buyouts under Carlyle's wing.

Amid national rollbacks in equity funding, one Selma-based group expanded its reach, awarding its 1,000th joy grant and proving investment is resistance.

Facing soaring demand, AI robotics firm TechForce is seeking a global manufacturing partner, signaling a major shift from pilot programs to mass production.

The AI investment frenzy is shifting from GPUs to the physical world of power, cooling, and real estate, creating a new class of high-value companies.

A publicly listed venture builder reports explosive growth and a radical new strategy: using a video game to democratize venture capital for everyone.

Cubist's new C2F platform uses confidential computing to solve a core Web3 dilemma, promising private, high-speed off-chain logic with on-chain guarantees.